Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Clinical trial update of veliparib combined with topotecan hydrochloride in adults with solid tumors, relapsed or refractory ovarian cancer,…
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer [Phase 2]
Phase 2 clinical trial evaluating ONM-100 as an intraoperative fluorescence imaging agent for cancer detection has completed enrollment with…
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Olaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian Cancer [Phase 2]
Phase 2 clinical trial update evaluating olaparib alone and in combination with pembrolizumab for ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy [Phase 3]
A Phase 3 trial evaluating high-dose inorganic selenium for preventing chemotherapy-induced peripheral neuropathy in ovarian cancer patients…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer [Phase 2]
Phase II trial of pembrolizumab with carboplatin and paclitaxel in ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors [Phase 2]
Phase 2 trial updating Paclitaxel plus Gemcitabine in refractory metastatic germ cell tumors (testicular germ cell tumors) and ovarian cance…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Open-label, multicenter Phase 1/2 trial evaluating PARP inhibitor E7449 as a single agent and in combination regimens for advanced solid tum…
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma [Phase 2]
Phase 2 study of DKN-01 as a monotherapy or with paclitaxel in recurrent epithelial endometrial cancer, epithelial ovarian cancer, or carcin…
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Clinical Outcomes for Offering Genetic Testing in a Tiered Approach [NA]
A completed clinical trial evaluating the outcomes of offering genetic testing in a tiered approach, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-30Clinical Trial Update: Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics) [Phase 4]
A Phase 4 clinical trial evaluating how propofol and sevoflurane anesthesia influence outcomes in patients with ovarian cancer is currently …
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Oregovomab and PLD in PARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment [Phase 2]
A Phase 2 clinical trial investigating oregovomab and pegylated liposomal doxorubicin (PLD) in patients with PARP inhibitor–resistant ovaria…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) [Phase 2]
Phase 2 safety-run-in update for weekly tisotumab vedotin in platinum-resistant ovarian cancer (innovaTV 208) completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer [Phase 2]
Phase 2 trial evaluating ALT-803 administered subcutaneously after initial ALT-803 treatment for ovarian cancer, fallopian tube cancer, and …
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) [Phase 1, Phase 2]
Phase 1/2 study evaluating Epacadostat in combination with Nivolumab in select advanced cancers; results have been posted following completi…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors [Phase 3]
Phase 3 clinical trial investigating TC or BEP chemotherapy regimens for ovarian malignant sex cord-stromal tumors; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors [Phase 3]
Phase 3 clinical trial evaluating TC or BEP chemotherapy in patients with malignant ovarian germ cell tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating AK104 in combination with chemotherapy as neoadjuvant treatment for advanced ovarian cancer is ongoing, …
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab [Phase 2]
Phase 2 trial update on the efficacy and safety of the fuzuloparib plus bevacizumab combination for recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Signal TrAnsduction Pathway Activity Analysis in OVarian cancER [Phase 2, Phase 3]
A Phase 2/3 clinical trial update focusing on signal transduction pathway activity analysis in recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100) [Phase 3]
Phase 3 trial JAVELIN OVARIAN PARP 100 evaluating avelumab with talazoparib in untreated advanced ovarian cancer was terminated; results pos…
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers [Phase 2]
Phase 2 trial update on atezolizumab and Vigil in advanced gynecological cancers, including ovarian, cervical, and uterine cancers, with com…
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: FT516 and IL2 With Enoblituzumab for Ovarian Cancer [Phase 1]
Phase 1 clinical trial update for FT516 and IL-2 with enoblituzumab in ovarian cancer-related conditions, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial update on the combination of cediranib and olaparib for recurrent cancers of the fallopian tube, ovary, or peritoneum…
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer [Phase 3]
Phase 3 trial comparing two chemotherapy regimens for ovarian cancer; results not yet available.